Table 1. Mean age of patients in land mark heart failure trials.[54].
Trial | Year | Study treatment | No. of patients | Mean age in years (approximate) |
SOLVD* | 1991 | Enalapril | 2569 | 61 |
DIG (main trial) | 1997 | Digoxin | 6800 | 63 |
RALES | 1999 | Spironolactone | 1663 | 65 |
CIBIS II* | 1999 | Bisoprolol | 2647 | 61 |
ATLAS | 1999 | Low-dose vs. high-dose lisinopril | 3793 | 64 |
COPERNICUS | 2001 | Carvedilol | 2289 | 63 |
BEST | 2001 | Bucindolol | 2706 | 60 |
EPHESUS | 2001 | Eplerenone | 6632 | 64 |
Val-HeFT | 2002 | Valsartan | 5010 | 65 |
MADIT II | 2002 | ICD | 1232 | 64 |
COMET | 2003 | Carvedilol vs. metoprolol | 3029 | 62 |
CARE HF | 2005 | CRT vs. medical therapy alone | 813 | 67 |
MADIT-CRT | 2009 | CRT-defibrillator vs. ICD | 1820 | 65 |
SHIFT | 2010 | Ivabradine | 6558 | 60 |
EMPHASIS | 2011 | Eplerenone | 2737 | 69 |
*SOLVD and CIBIS II had age < 80 years in the inclusion criteria. CRT: cardiac resynchronization therapy; ICD: internal cardioverter defibrillator;